[1]
“INCRETIN-BASED PHARMACOTHERAPY FOR OBESITY: A COMPARATIVE NARRATIVE REVIEW OF GLP-1, DUAL AND TRIPLE AGONISTS AND COMBINATION THERAPIES”, IJITSS, vol. 5, no. 4(48), Dec. 2025, doi: 10.31435/ijitss.4(48).2025.4388.